Leadless cardiac pacing systems: current status and future prospects.

Leadless cardiac pacing systems: current status and future prospects.
Expert Rev Med Devices. 2019 Oct 28;:
Authors: Beurskens NEG, Breeman KTN, Dasselaar KJ, Meijer AC, Quast ABE, Tjong FVY, Knops RE
Abstract
Introduction: Permanent transvenous pacemaker therapy is an essential management option in patients with symptomatic bradyarrhythmias, but harbors a concomitant risk of serious complications. As most complications are lead- or pocket-related, intracardiac leadless pacemaker therapy has the potential to positively impact patient outcome. Since the first leadless pacemaker implant in 2012, many studies have been conducted to evaluate effectiveness, safety and applicability of this novel pacing approach. Areas covered: This review will cover the current status of leadless pacemaker technology. Available safety and efficacy outcomes, current area of indication, and end-of-life management will be evaluated. Furthermore, future perspectives for clinical practice and new pacing modalities are discussed. Expert opinion: The first-generation leadless pacemakers are a promising innovation that provide safe and efficient single-chamber pacing therapy without the use of transvenous pacemaker leads. Yet, broad implementation of this technology is hampered by limitations of the current leadless devices, such as end-of-life management and its single-chamber pacing indication. Further innovations such as leadless dual-chamber pacing therapy, l...

Source: Expert Review of Medical Devices - October 30, 2019 Category: Medical Devices Tags: Expert Rev Med Devices Source Type: research